Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 4/20 | 0.60 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.60 |
| ▸ | SRC | P12931 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.60 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.60 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.60 |
| ▸ | LDHA | P00338 | 1/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.60 |
| ▸ | FBP1 | P09467 | 1/20 | 0.60 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.60 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.60 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.60 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.60 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.60 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16108843 | 0.89 | P2RY2 (0.61) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL7080308 | 0.89 | DNPH1 (0.46) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL4261443 | 0.87 | P2RY2 (0.64) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL7231385 | 0.86 | P2RY2 (0.64) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL756245 | 0.86 | P2RY2 (0.64) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL1641392 | 0.85 | TAS1R3 (0.65) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL9750489 | 0.85 | P2RY2 (0.56) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| Water SCHEMBL443839 | 0.85 | P2RY2 (0.63) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL5320373 | 0.85 | P2RY2 (0.63) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 | |
| SCHEMBL2791974 | 0.85 | P2RY2 (0.63) | P2RY2P2RY1SRCSMN1; SMN2ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2405275-B1 | Method for measuring glycated albumin contained in serum or plasma using mannitol as stabiliser for a control serum or plasma. | BML INC (JP) | 2018-10-10 | — | — | EP | claimed |
| EP-2222229-B1 | DEVICE FOR BIOCHEMICAL PROCESSING AND ANALYSIS OF A SAMPLE | LIFEASSAYS AB PUBL (SE) | 2013-02-20 | — | — | EP | claimed |
| EP-1850134-B1 | Method and Apparatus for the determination of the Thromboyte function and flow conditions | SIEMENS HEALTHCARE DIAGNOSTICS (DE) | 2013-01-30 | — | — | EP | claimed |
| EP-2044212-B1 | METHODS FOR IDENTIFYING PATIENTS WITH INCREASED RISK OF AN ADVERSE CARDIOVASCULAR EVENT | SIEMENS HEALTHCARE DIAGNOSTICS (US) | 2012-03-21 | — | — | EP | claimed |
| EP-1895303-B1 | METHOD OF ASSAYING 1, 5-ANHYDROGLUCITOL BY USING WHOLE BLOOD | NIPPON KAYAKU KK (JP) | 2011-05-11 | — | — | EP | claimed |
| EP-1616963-B1 | Process for producing dipeptides or dipeptide derivatives | KYOWA HAKKO BIO CO LTD (JP) | 2009-11-18 | — | — | EP | claimed |
| EP-1139793-B1 | INHIBITORS OF THE BITTER TASTE RESPONSE | SINAI SCHOOL MEDICINE (US) | 2009-10-14 | — | — | EP | claimed |
| EP-1753774-B1 | 2\"-NITROBENZYL-MODIFIED RIBONUCLEOTIDES | ASM SCIENT INC (US) | 2008-09-10 | — | — | EP | claimed |
| EP-1850134-A1 | Method and Apparatus for the determination of the Thromboyte function and flow conditions | Dade Behring Marburg GmbH (DE) | 2007-10-31 | — | — | EP | claimed |
| EP-1850135-A1 | Method for determining the thrombocyte function and flow conditions | Dade Behring Marburg GmbH (DE) | 2007-10-31 | — | — | EP | claimed |
| WO-1999029895-A1 | STABILISED REAGENT AND METHOD FOR DETERMINING CREATINE KINASE | ROCHE DIAGNOSTICS GMBH (DE) | 1999-06-17 | — | — | WO | claimed |
| EP-0913483-A2 | Method and reagent for the determination of creatine kinase | Roche Diagnostics GmbH (DE) | 1999-05-06 | — | — | EP | claimed |
| EP-0566140-B1 | Method for producing dinucleoside polyphosphate, nucleoside polyphosphate or derivatives thereof | UNITIKA LTD (JP) | 1998-07-01 | — | — | EP | claimed |
| EP-0352477-B1 | Use of adenosine 5'-phosphat in the treatment of cancer cachexia | RAPAPORT ELIEZER (US) | 1995-01-18 | — | — | EP | claimed |
| EP-0385486-B1 | Process for producing fructose-1,6-diphosphate | UNITIKA LTD (JP) | 1994-06-22 | — | — | EP | claimed |
| EP-0247819-B1 | PROCESS FOR PRODUCING DIADENOSINE TETRAPHOSPHATE AND DERIVATIVES THEREOF | UNITIKA LTD. (JP) | 1991-07-24 | — | — | EP | claimed |
| EP-0239222-B1 | ANALYTICAL ELEMENT CONTAINING PHOTOSENSITIVE COMPOUND AND FILTER LAYER AND METHOD OF USE | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-12-05 | — | — | EP | claimed |
| EP-0200541-B1 | IMMUNOCHEMICAL METHOD AND ANALYTICAL COMPOSITION AND ELEMENT FOR DETERMINATION OF CREATINE KINASE-MB | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-10-03 | — | — | EP | claimed |
| EP-0202094-B1 | PROCESS FOR PRODUCING PHYSIOLOGICALLY ACTIVE SUBSTANCE | UNITIKA LTD. (JP) | 1988-09-21 | — | — | EP | claimed |
| EP-0100022-B1 | PHARMACEUTICAL COMPOSITION CONTAINING ADENOSINE DERIVATIVES FOR USE IN TREATING TUMOURS | Rapaport, Eliezer (US) | 1988-04-20 | — | — | EP | claimed |